Table 2.
Success rate of SLT
| At 6 months (n = 33) | At 1 year (n = 28) | |||
|---|---|---|---|---|
|
n (% eyes) (with medicines) |
n (% eyes) (without medicines) |
n (% eyes) (with medicines) |
n (% eyes) (without medicines) |
|
| IOP reduction | ||||
| ≥4 mm Hg | 28 (84.84) | 24 (72.72) | 23 (82.15) | 16 (57.14) |
| ≥6 mm Hg | 19 (57.57) | 16 (48.48) | 19 (67.85) | 13 (46.42) |
| ≥20% | 20 (60.60) | 17 (51.51) | 19 (67.85) | 13 (46.42) |
| ≥25% | 14 (42.42) | 12 (36.36) | 18 (64.28) | 11 (39.28) |
| IOP | ||||
| <12 mm Hg | – | – | – | – |
| 12–15 mm Hg | 2 (6.00) | 3 (9.00) | 4 (14.28) | 10 (35.70) |
| 16–18 mm Hg | 15 (45.45) | 17 (51.52) | 7 (25.00) | 11 (39.28) |
| 19–21 mm Hg | 10 (30.30) | 10 (30.30) | 6 (21.43) | 6 (21.42) |
| >21 mm Hg | 2 (6.00) | 3 (9.00) | 1 (3.60) | 1 (3.60) |
IOP intraocular pressure